Shared Decision-Making on Using a CDK4/6 Inhibitor plus an Aromatase Inhibitor for HR+/HER2− Metastatic Breast Cancer: A Podcast

ABSTRACT: Shared decision-making involves patients engaging with their physicians to make informed decisions regarding treatment selection, a process that empowers patients and ensures that treatment decisions reflect their individual values and preferences. However, shared decision-making can be ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Brian, Lusen, Rita, Chick, Ella, Kline, Lisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10673755/
https://www.ncbi.nlm.nih.gov/pubmed/37775726
http://dx.doi.org/10.1007/s40487-023-00237-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10673755/
https://www.ncbi.nlm.nih.gov/pubmed/37775726
http://dx.doi.org/10.1007/s40487-023-00237-4

Ejemplares similares